Publication details

Thrombotic Events in Neonates Receiving Recombinant Factor VIIa or Fresh Frozen Plasma

Authors

PUETZ J. BRABEC Petr DARLING G.

Year of publication 2009
Type Article in Periodical
Magazine / Source Pediatric Blood & Cancer
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords bleeding; coagulopathy; fresh frozen plasma; neonate; rFVIIa
Description Numerous recent reports have described the use of recombinant factor VIIa (rFVIIa) in non-hemophilia bleeding Situations for achievement of hemostasis. However, its use in clinical situations other than hemophilia patients with inhibitors has been complicated by some reports of thrombotic events. rFVIIa has been used successfully to treat coagulopathic and/or bleeding neonates. The prevalence of thrombotic events in these neonates is completely unknown. This study was initiated to determine the risk of thrombotic events associated with rFVIIa use in neonates. Procedure. All published literature in non-hemophilic, non-congenital factor VII deficient neonates receiving rFVIIa was reviewed. In addition, all data submitted to the SeveN Bleep Registry, a web-based registry of rFVIIa uses in non-hemophilic children was analyzed.

You are running an old browser version. We recommend updating your browser to its latest version.

More info